Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
15 Cards in this Set
- Front
- Back
First-line tx for IBD
|
5-aminosalicylates
(thought to act topically) |
|
MoA of 5-ASA
|
topically, inhibit COX-1, immunosuppressive activity, impair WBC adhesion/cytokine synthesis
|
|
Differences between Pentasa, Asacol, and Azo-compounds.
|
location of release of oral 5-ASA
delayed release, pH dependent release, bacterial breakdown |
|
impact of 5-ASA
|
helps 70% of pts with IBD in remission
|
|
Indication for corticosteroids
|
active ulcerative colitis and CD
no role in maintenance |
|
key side effect for prednisone in IBD
|
osteoporosis
hyperglycemia |
|
Benefit of budesonide?
|
higher potency, rapid 1st pass metabolism, less systemic effects
|
|
Indications for steroid sparing agents
|
>2 courses of steroids in 1 yr
relapse within 6 weeks post-op for complicated CD |
|
2 main steroid sparing agents
|
azathioprine
-inhibit ribonucleotide synthesis methotrexate -inhibit DHFR |
|
Azathioprine efficacy in IBD
|
50-70%
|
|
Most common adverse effect in MTX
|
N/V
|
|
Anti TNF causes what?
|
Blocks TNF, which summons inflammation and dec immune response
|
|
How does lack of response to biologics often occur?
|
Body makes antibodies against agents b/c they are proteins
|
|
General UC tx plan
|
5-ASA -> Corticosteroids -> immunomodulators -> surgery/cyclosporin/infliximab
|
|
General CD tx plan
|
5-ASAs/budesonide/antibiotics -> corticosteroids/immunomodulators -> surgery
|